VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high unmet need. 

Education

Pharmaceutical

VistaGen Therapeutics

Shawn K. Singh

Margie Schneider

Ester Salmán

Cindy Anderson

Mark Flather

Mark A. McPartland

Allen Cato III

Louis Monti

Ross A. Baker

Greg Weilersbacher

Trisha Fitzmaurice

Jessica R. Haskell

Joshua Prince

Reid Adler

Mark J. Ginski

The executive team at VistaGen Therapeutics has experience in the pharmaceutical industry, specifically in neurology/psychiatry, experimental medicine, and medical science. They also have experience leading projects in discovery. The team is educated, with degrees from Duke University School of Medicine.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at VistaGen Therapeutics

Leadership Team

Board of Directors